Egypt’s drug regulator is looking to boost ties with China on medicines and vaccines.
- EDA chief Ali El‑Ghamrawy met NMPA deputy Yang Xing in Beijing to discuss regulatory coordination.
- Both sides want to share expertise, transfer technology and create joint ventures in drug and vaccine production.
- Egypt aims to leverage its growing manufacturing base and China’s advanced tech to become a regional pharma hub.
The dialogue marks a push for stronger institutional links and new investment opportunities across the two markets.